Thermo Fisher Scientific Inc. (TMO)

Market Cap	231.76B
Revenue (ttm)	42.49B
Net Income (ttm)	6.03B
Shares Out	381.72M
EPS (ttm)	15.59
PE Ratio	38.94
Forward PE	26.99
Dividend	$1.56 (0.26%)
Ex-Dividend Date	Sep 13, 2024

Volume	2,346,856
Open	600.85
Previous Close	594.50
Day's Range	599.30 - 614.65
52-Week Range	415.60 - 614.64
Beta	0.77
Analysts	Buy
Price Target	615.24 (+1.33%)
Earnings Date	Jul 24, 2024

About TMO

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 122,000
• Stock Exchange: NYSE
• Ticker Symbol: TMO

Financial Performance

In 2023, Thermo Fisher's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.

Analyst Forecast

According to 20 analysts, the average rating for TMO stock is "Buy." The 12-month stock price forecast is $615.24, which is an increase of 1.33% from the latest price.

Price Target

$615.24

(1.33% upside)

Analyst Consensus: Buy